1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

22 May 2024
Admin
News Article

Indoco Remedies Receives US FDA Final Approval for Pregabalin Capsules

Overview

Indoco Remedies Ltd., a fully integrated, research-oriented pharmaceutical company, announced the receipt of final approval from the US FDA for Abbreviated New Drug Application (ANDA) for pregabalin capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg. This is a generic equivalent of the Reference Listed Drug, Lyrica capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg, of Upjohn US 2 LLC.

Manufacturing Facility

This product, pregabalin capsules will be manufactured by Indoco Remedies Limited, at their manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa – 403722 in India.

Pregabalin: Indication

Pregabalin is used for neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia and fibromyalgia.

Words from Managing Director: Indoco Remedies

Commenting on the achievement, Aditi Panandikar, managing director said, “This development marks a significant milestone for us and is a testament to our commitment to quality and regulatory compliance. We remain focused on quality, excellence and delivering value to our stakeholders.”

Indoco Remedies

Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence.
The company’s turnover is US$ 212 million with a human capital of over 6,000 employees, including over 400 skilled scientists and field staff who are the strength of the organization.